Inventor · disambiguated record
Andrew Madin
Also filed as: MADIN ANDREW
54 granted patents·4 pending applications·444 citations·filing 1995–2024
98Inventor score
Files withMERCK SHARP & DOHME24MISSION THERAPEUTICS LTD14GENENTECH INC11BERDINI VALERIO3CASTRO PINEIRO JOSE LUIS1
Top patents by PatentIndex Score
58 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0294US9926307B2CompoundsMISSION THERAPEUTICS LTD·Filed 2015·Granted Mar 27, 2018·14 cites·16 claims
- 0392US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 0490US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0589US10392380B2CompoundsMISSION THERAPEUTICS LTD·Filed 2018·Granted Aug 27, 2019·6 cites·17 claims
- 0688US7638629B2Piperidines and related compounds for treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2005·Granted Dec 29, 2009·13 cites·8 claims
- 0787US11130748B2CompoundsMISSION THERAPEUTICS LTD·Filed 2016·Granted Sep 28, 2021·3 cites·12 claims
- 0887US10774078B2CompoundsMISSION THERAPEUTICS LTD·Filed 2019·Granted Sep 15, 2020·2 cites·10 claims
- 0987US8131527B1FGFR pharmacophore compoundsSAXTY GORDON·Filed 2007·Granted Mar 6, 2012·17 cites·47 claims
- 1087US7144910B2Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2003·Granted Dec 5, 2006·27 cites·10 claims
- 1186US11472798B2CompoundsMISSION THERAPEUTICS LTD·Filed 2020·Granted Oct 18, 2022·1 cites·11 claims
- 1286US7138400B2Sulfamides as gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2001·Granted Nov 21, 2006·32 cites·6 claims
- 1386US7105509B2Benzodiazepine derivatives as APP modulatorsMERCK SHARP & DOHME·Filed 2001·Granted Sep 12, 2006·21 cites·6 claims
- 1485US10640498B2CompoundsMISSION THERAPEUTICS LTD·Filed 2017·Granted May 5, 2020·6 cites·17 claims
- 1585US7282513B2Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretaseMERCK SHARP & DOHME·Filed 2006·Granted Oct 16, 2007·7 cites·10 claims
- 1683US8513276B2Imidazo[1,2-a]pyridine compounds for use in treating cancerBERDINI VALERIO·Filed 2007·Granted Aug 20, 2013·8 cites·16 claims
- 1782US6828322B2Triazolo-pyridazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2003·Granted Dec 7, 2004·14 cites·15 claims
- 1881US11993595B2CompoundsMISSION THERAPEUTICS LTD·Filed 2022·Granted May 28, 2024·0 cites·10 claims
- 1981US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 2079US6255305B1Substituted triazolo-pyridazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 1997·Granted Jul 3, 2001·49 cites·15 claims
- 2178US7041689B2Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretaseMERCK SHARP & DOHME·Filed 2003·Granted May 9, 2006·7 cites·16 claims
- 2277US6107321ADiazabicyclooctane derivatives having selective 5-HT1Dalpha agonist activityMERCK SHARP & DOHME·Filed 1996·Granted Aug 22, 2000·21 cites·4 claims
- 2376US7205434B2Sulphonamides for control of beta-amyloid productionMERCK SHARP & DOHME·Filed 2002·Granted Apr 17, 2007·8 cites·8 claims
- 2476US5854268AAzetidine, pyrrolidine and piperidine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Dec 29, 1998·45 cites·10 claims
- 2575US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2673US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 2773US6140347AAzetidine, pyrrolidine and piperidine derivatives as 5-HT receptor agonistsMERCK SHARP & DOHME·Filed 1997·Granted Oct 31, 2000·18 cites·9 claims
- 2872US10683269B22-cyanoisoindoline derivatives for treating cancerMISSION THERAPEUTICS LTD·Filed 2017·Granted Jun 16, 2020·1 cites·15 claims
- 2970US7365196B2Sulphonamido-substituted bridged bicycloalkyl derivativesMERCK SHARP & DOHME·Filed 2001·Granted Apr 29, 2008·6 cites·10 claims
- 3070US6579875B1Triazolo-pyridazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 1999·Granted Jun 17, 2003·22 cites·20 claims
- 3168US11958833B2CompoundsMISSION THERAPEUTICS LTD·Filed 2021·Granted Apr 16, 2024·0 cites·14 claims
- 3267US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 3367US8822455B2Fused aminodihydrothiazine derivativesDIMOPOULOS PASCHALIS·Filed 2012·Granted Sep 2, 2014·2 cites·13 claims
- 3464US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 3562US6949549B2Imidazolophthalazine derivatives as ligands for GABAA receptorsMERCK SHARP & DOHME·Filed 2001·Granted Sep 27, 2005·2 cites·6 claims
- 3662US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 3762US2008070895A1Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretaseCOLLINS IAN J·Filed 2007·Application pending·0 cites
- 3861US6355798B1Triazolo-pyridazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 1999·Granted Mar 12, 2002·17 cites·8 claims
- 3957US6303605B1Triazolo-pyridazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 1999·Granted Oct 16, 2001·12 cites·7 claims
- 4055US6630471B1Substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefromMERCK SHARP & DOHME·Filed 1999·Granted Oct 7, 2003·12 cites·6 claims
- 4154US12208088B2Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofGENENTECH INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 4254US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 4353US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 4453US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 4547US7514459B2Gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Apr 7, 2009·0 cites·12 claims
- 4646US11414402B2Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitorsMISSION THERAPEUTICS LTD·Filed 2018·Granted Aug 16, 2022·0 cites·14 claims
- 4746US7427621B2Cyclic sulfamides for inhibition of gamma-secretaseMERCK SHARP & DOHME·Filed 2003·Granted Sep 23, 2008·0 cites·8 claims
- 4846US5854247APiperazine, piperidine and tetrahydropyridine derivatives useful as 5-HT1 recepter agonistsMERCK SHARP & DOHME·Filed 1995·Granted Dec 29, 1998·6 cites·9 claims
- 4945US7985758B2Piperidine derivatives for treatment of Alzheimer's diseaseMERCK SHARP & DOHME·Filed 2007·Granted Jul 26, 2011·0 cites·9 claims
- 5043US11370784B2Cyano-substituted heterocycles with activity as inhibitors of USP30MISSION THERAPEUTICS LTD·Filed 2017·Granted Jun 28, 2022·0 cites·14 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →